,,ii #aahth ,,congress #ast ,session ,s4 #bded ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #bj1 #bjbc,mr4 ,lankford introduced the following bill2 which was read twice and referred to the ,committee on ,foreign ,relations ,a ,,bill ,to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the ,people's ,republic of ,china for finished pharmaceutical products and active pharmaceutical ingredients4 #a4 ,short title ,this ,act may be cited as the ,pharmaceutical ,supply ,chain ,security ,act4 #b4 ,reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the ,people's ,republic of ,china 7a7 ,report on pharmaceuticals imported from the ,people's ,republic of ,china 7#a7 ,in general ,not later than #ahj days after the date of the enactment of this ,act1 the ,commissioner of ,food and ,drugs1 in consultation with the ,united ,states ,trade ,representative1 shall submit to the appropriate congressional committees a report that sets forth a list of-- 7,a7 each finished pharmaceutical product that is imported into the ,united ,states from the ,people's ,republic of ,china in a quantity that exceeds #bj percent of the quantity of the product available for use in the ,united ,states2 and 7,b7 each active pharmaceutical ingredient that is imported into the ,united ,states from the ,people's ,republic of ,china in a quantity that exceeds #bj percent of the quantity of the ingredient available for use in the ,united ,states4 7#b7 ,confidential ,the report required by paragraph 7#a7 shall be confidential and may not be disclosed to the public4 7b7 ,strategy for pharmaceutical supply chain resiliency 7#a7 ,in general ,the ,president shall develop a comprehensive strategy to address the national security threat posed by the control by the ,people's ,republic of ,china of the global supply of finished pharmaceutical products and active pharmaceutical ingredients4 7#b7 ,elements ,the strategy required by paragraph 7#a7 shall include efforts to develop a more reliable and secure supply chain for finished pharmaceutical products and active pharmaceutical ingredients1 including manufacturing and production projects that-- 7,a7 contribute to the development of a more reliable and secure supply chain for such products and ingredients2 7,b7 reduce reliance on the ,people's ,republic of ,china for such products and ingredients2 and 7,c7 facilitate cooperation with the governments of other countries in a concerted effort to make significant strategic investments in research1 development1 and manufacturing of such products and ingredients4 7#c7 ,report required 7,a7 ,in general ,not later than #ahj days after the date of the enactment of this ,act1 the ,president shall submit to the appropriate congressional committees a report on the strategy required by paragraph 7#a74 7,b7 ,elements ,the report required in paragraph 7#a7 shall include-- 7i7 a description of the extent of the engagement of the ,united ,states ,international ,development ,finance ,corporation with the governments of other countries to promote shared investment in and development of finished pharmaceutical products and active pharmaceutical ingredients2 and 7ii7 a description of the work of the ,united ,states ,trade ,representative to engage with the governments of those countries to decrease trade barriers for the development1 production1 refinement1 and transportation of such products and ingredients4 7c7 ,investments in pharmaceutical supply chain resiliency 7#a7 ,in general ,in support of the strategy required by subsection 7b71 the ,united ,states ,international ,development ,finance ,corporation shall prioritize providing support under title ,,ii of the ,better ,utilization of ,investments ,leading to ,development ,act of #bjah 7#bb ,u4,s4,c4 #ifba et seq47 for manufacturing and production of finished pharmaceutical products and active pharmaceutical ingredients1 including projects that-- 7,a7 contribute to the development of a more reliable and secure supply chain for such products and ingredients2 7,b7 reduce reliance on the ,people's ,republic of ,china for such products and ingredients2 and 7,c7 facilitate cooperation with the governments of other countries in a concerted effort to make significant strategic investments in research1 development1 and manufacturing of such products and ingredients4 7#b7 ,certification requirement ,the ,united ,states ,international ,development ,finance ,corporation may not provide support under paragraph 7#a7 for a project relating to the manufacturing or production of a finished pharmaceutical product unless the entity receiving the support certifies that-- 7,a7 not more than #be percent of the active pharmaceutical ingredients used in the product are sourced from a single country of origin that is a nonmarket economy country1 as defined by the ,secretary of ,commerce2 and 7,b7 the entity is not controlled1 in whole or in part1 by an entity organized under the laws of1 or otherwise subject to the jurisdiction of1 a nonmarket economy country4 7d7 ,appropriate congressional committees defined ,in this section1 the term appropriate congressional committees means-- 7#a7 the ,committee on ,health1 ,education1 ,labor1 and ,pensions1 the ,committee on ,commerce1 ,science1 and ,transportation1 the ,committee on ,foreign ,relations1 and the ,committee on ,finance of the ,senate2 and 7#b7 the ,committee on ,energy and ,commerce1 the ,committee on ,foreign ,affairs1 and the ,committee on ,ways and ,means of the ,house of ,representatives4